Skip to main content

Table 1 Baseline characteristics of patients

From: Efficacy of pamidronate in children with chronic non-bacterial osteitis using whole body MRI as a marker of disease activity

Female: Male

3.18: 1

Median age at diagnosis (IQR, years)

11.6 (10–13)

Median time to diagnosis (IQR, months)

12 (5–24)

Clinical characteristics (%)

Bone pain

36 (78.3)

Bone swelling

10 (21.7)

Synovitis

3 (6.5)

Arthritis

6 (13)

Pustulosis

3 (6.5)

Psoriasis

3 (6.5)

IBDa

1 (2.2)

Family history of psoriasis (%)

7 (15.2)

Family history of IBD (%)

2 (4.3)

Bone biopsy (%)

29 (63)

Lesions pre-treatment on WB-MRI

162

Treatment (%)

NSAIDs

35 (76)

Pamidronate

46 (100)

Corticosteroids

4 (8.7)

Methotrexate

5 (10.9)

TNF blockers (n = 40)

5 (12.5)

  1. aIBD Inflammatory bowel disease